Reaction
Therapeutic Product Effect Prolonged reporting signals
As of the last recalculation, Therapeutic Product Effect Prolonged appears in 442 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 94.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 18 | 94.5 | 94.7 |
| Rocuronium Bromide | 18 | 75.0 | 75.1 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 11 | 61.7 | 61.7 |
| Sodium Oxybate | 57 | 46.6 | 46.6 |
| Sevoflurane | 4 | 22.9 | 22.9 |
| Rimegepant Sulfate | 4 | 15.0 | 15.0 |